TRACON Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 EPS Results.
TRACON Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 EPS Results.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSINTX Techs (NASDAQ:SINT) stock moved upwards by 143.1% to $0.13 during Wednesday's pre-market session. The company's market cap stands at $16.4 million. The company's, Q1 earnings came out 2 d
Earnings Call Summary | Tracon Pharmaceuticals(TCON.US) Q1 2024 Earnings Conference
The following is a summary of the TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Call Transcript:Financial Performance:TRACON's R&D expenses were down to $1.9 million in Q1 2024 from $5 million
TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Call Transcript
TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Call Transcript
Tracon Pharmaceuticals | 10-Q: Quarterly report
Tracon Pharma: Final Response Assessment Data in All Patients From ENVASARC Phase 2 Pivotal Trial Expected in 3Q
Tracon Pharma: Final Response Assessment Data in All Patients From ENVASARC Phase 2 Pivotal Trial Expected in 3Q
Earnings Flash (TCON) TRACON PHARMACEUTICALS Posts Q1 Revenue $100,000
04:04 PM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (TCON) TRACON PHARMACEUTICALS Posts Q1 Revenue $100,000
Tracon Pharmaceuticals 1Q Loss/Shr $1.33 >TCON
Tracon Pharmaceuticals 1Q Loss/Shr $1.33 >TCON
David Lazar Joins TRACON Pharmaceuticals as Chief Business Officer
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its
INVO, EZGO and WISA Among Pre-market Losers
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersTrevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. The company's market cap stands at $9.2 million. Mustang Bio (NASDAQ:MBIO) stock increased by 1
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE:TRV) fell sharply during Wednesday's session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' e
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersSoligenix (NASDAQ:SNGX) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. Longeveron (NASDAQ:LGVN) shares increased by 51.47
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Shares of Medical Properties Trust, Inc. (NYSE:MPW) rose sharply in today's pre-market trading after the company announced that it sold its majority interest in Utah Hospitals. Medical Properties Tru
TRACON Pharmaceuticals to Offer Stock
TRACON Pharmaceuticals to Offer Stock
Buy Rating Reaffirmed for TRACON Pharmaceuticals Post-Reverse Split and Envafolimab Valuation Update
Analysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON) and IN8bio (INAB)
Aptevo Therapeutics, TRACON Pharmaceuticals, Biosig Technologies Among Healthcare Movers
No Data